ADBiotech Co., Ltd. (KOSDAQ:179530)
1,568.00
+58.00 (3.84%)
At close: Mar 9, 2026
ADBiotech Market Cap
ADBiotech has a market cap or net worth of 30.86 billion as of March 9, 2026. Its market cap has increased by 53.45% in one year.
Market Cap
30.86B
Enterprise Value
30.37B
Revenue
14.57B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,568.00
Market Cap Chart
Since December 24, 2019, ADBiotech's market cap has increased from 25.35B to 30.86B, an increase of 21.75%. That is a compound annual growth rate of 3.22%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MOA Life Plus | 27.14B |
| Epibiotech | 33.33B |
| Eutilex.Co.,Ltd | 35.32B |
| Kainos Medicine | 35.56B |
| SCM Lifescience | 38.01B |
| Moogene Medi | 20.15B |
| J2KBIO | 45.32B |
| Plumbline Life Sciences | 18.69B |